# Efficacy and Safety of Telitacicept Combined With Baricitinib for Refractory Rheumatoid Arthritis

> **NCT07491016** · — · RECRUITING · sponsor: **Zhejiang Provincial People's Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Telitacicept
- Treatment Compliance
- Rheumatoid Arthritis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07491016
- **Lead sponsor:** Zhejiang Provincial People's Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-01
- **Primary completion:** 2027-03-30
- **Final completion:** 2028-03-30
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07491016

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07491016, "Efficacy and Safety of Telitacicept Combined With Baricitinib for Refractory Rheumatoid Arthritis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT07491016. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*